[go: up one dir, main page]

WO2009004544A3 - Artificial vessels, kits and methods - Google Patents

Artificial vessels, kits and methods Download PDF

Info

Publication number
WO2009004544A3
WO2009004544A3 PCT/IB2008/052578 IB2008052578W WO2009004544A3 WO 2009004544 A3 WO2009004544 A3 WO 2009004544A3 IB 2008052578 W IB2008052578 W IB 2008052578W WO 2009004544 A3 WO2009004544 A3 WO 2009004544A3
Authority
WO
WIPO (PCT)
Prior art keywords
vessel
artificial
methods
protein
elastic protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/052578
Other languages
French (fr)
Other versions
WO2009004544A2 (en
Inventor
Han Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2009004544A2 publication Critical patent/WO2009004544A2/en
Anticipated expiration legal-status Critical
Publication of WO2009004544A3 publication Critical patent/WO2009004544A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

An artificial vessel comprises elastic protein and vessel growth stimulator capable of stimulating vessel endothelial cell growth. Another artificial vessel comprises a tube formed of elastic protein and at least one element attached to the tube for physically stimulating vessel endothelial cell growth. Implant kits comprise such artificial vessels. Methods of manufacturing an artificial vessel using recombinant techniques comprise inducing expression of an elastic protein- vessel growth stimulator fusion protein from a fusion gene of an elastic protein and a vessel growth stimulator.
PCT/IB2008/052578 2007-06-29 2008-06-26 Artificial vessels, kits and methods Ceased WO2009004544A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93788707P 2007-06-29 2007-06-29
US60/937,887 2007-06-29

Publications (2)

Publication Number Publication Date
WO2009004544A2 WO2009004544A2 (en) 2009-01-08
WO2009004544A3 true WO2009004544A3 (en) 2010-07-15

Family

ID=40226602

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/052578 Ceased WO2009004544A2 (en) 2007-06-29 2008-06-26 Artificial vessels, kits and methods

Country Status (1)

Country Link
WO (1) WO2009004544A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105327399B (en) * 2015-10-27 2017-12-22 苏州大学 Construction method of artificial blood vessel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1008724C2 (en) * 1998-03-27 1999-09-28 Stichting Tech Wetenschapp Production of an artificial blood vessel comprising porous plastics tube coated with collagen material
US20040115176A1 (en) * 2002-10-23 2004-06-17 Swartz Daniel D. Fibrin-based tissue-engineered vasculature
EP1609492A1 (en) * 2003-03-31 2005-12-28 Teijin Limited Molded elastin article and process for producing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1008724C2 (en) * 1998-03-27 1999-09-28 Stichting Tech Wetenschapp Production of an artificial blood vessel comprising porous plastics tube coated with collagen material
US20040115176A1 (en) * 2002-10-23 2004-06-17 Swartz Daniel D. Fibrin-based tissue-engineered vasculature
EP1609492A1 (en) * 2003-03-31 2005-12-28 Teijin Limited Molded elastin article and process for producing the same

Also Published As

Publication number Publication date
WO2009004544A2 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
ZA200606102B (en) Tissue system with undifferentiated stem cells derived from corneal limbus
EP3061808A3 (en) Culture medium for epithelial stem cells and organoids comprising said stem cells
WO2006099372A3 (en) Tissue engineered blood vessels
WO2006099334A3 (en) Production of tissue engineered heart valves
WO2008106192A3 (en) Reinforced medical implants
EP2593117A4 (en) BIOCOMPATIBLE SUBSTRATE FOR FACILITATING INTERCONNECTIONS BETWEEN STEM CELLS AND TARGET TISSUES AND ASSOCIATED IMPLANTATION METHODS
WO2020023888A3 (en) Compositions and methods for tcr reprogramming using target specific fusion proteins
WO2004108883A3 (en) Transducible dna-binding proteins
WO2007030743A3 (en) Cochlear implants containing biological cells and uses thereof
IL223376A (en) Inactivated drosophila artificial antigen presenting cells with crosslinked dna
WO2010131821A1 (en) Recombinant protein of fibroblast growth factor having adhesive activity for stem cells and method for culturing stem cells using the same
WO2012088238A3 (en) Intervertebralimplants and systems
WO2009009086A3 (en) Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression
WO2008076371A3 (en) Method for replicating influenza virus in culture
WO2014186160A8 (en) Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
EP4065684A4 (en) Thymus organoids bioengineered form human pluripotent stem cells
EP3761031A4 (en) Method for isolating cell nuclei having enhanced antigenicity from immobilized cells or ffpe tissue section, and antigen activator and kit therefor
WO2009022656A1 (en) Recombinant mammalian cells, method of producing recombinant mammalian cells and method of producing target protein
WO2011060357A3 (en) Engineered xenogeneic cells for repair of biological tissue
EP1753451A4 (en) LOCAL DELIVERY OF GROWTH FACTORS FOR THE TRANSPLANTATION OF STEM CELLS
WO2009004544A3 (en) Artificial vessels, kits and methods
WO2011143400A3 (en) Method and composition for inducing human pluripotent stem cells
WO2007055823A3 (en) Gpcr expressing cell lines and antibodies
UA100849C2 (en) Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE
EP1950307B8 (en) Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus spike protein

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31.03.2010)

122 Ep: pct application non-entry in european phase

Ref document number: 08776534

Country of ref document: EP

Kind code of ref document: A2